HEALTHCARE GLOBAL ENTERPRISES
|
|
| BOM : 539787     NSE : HCG     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Oct 30,2025 |
|
Price(EOD): ₹ 776.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 10,944.42 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HEALTHCARE GLOBAL ENTERPRISES | 2.4% | 23.5% | 81% |
| MAX HEALTHCARE INSTITUTE | -0.5% | 6% | 26.9% |
| APOLLO HOSPITALS ENTERPRISE | -0.6% | 4.7% | 13.3% |
| FORTIS HEALTHCARE | 0.7% | 7.6% | 80.9% |
| GLOBAL HEALTH | 1.8% | 3.9% | 29.7% |
| NARAYANA HRUDAYALAYA | 3.5% | 1.1% | 45.5% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 1.1% | 3.8% | 40.7% |
| DR LAL PATHLABS | 1.5% | -1.4% | -1.5% |
| ASTER DM HEALTHCARE | -1.3% | 11.9% | 55.6% |
FUNDAMENTAL ANALYSIS OF HEALTHCARE GLOBAL ENTERPRISES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF HEALTHCARE GLOBAL ENTERPRISES
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
275.54
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 39.72 Cr
[Latest Qtr - Jun2025 - Consolidated Results ] 12.16
P/B Calculated based on Book Value of Rs 900.09 Cr
[Latest Year - Mar2025 - Consolidated Results ] 4.74
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,310.43 Cr
[Latest Qtr - Jun2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
60% 67% 78% |
SHARE PRICE MOMENTUM OF HEALTHCARE GLOBAL ENTERPRISES
HEALTHCARE GLOBAL ENTERPRISES vs SENSEX
DEBT OF HEALTHCARE GLOBAL ENTERPRISES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.56 0.36 0.11 0.34 |
1.11 0.83 0.47 0.8 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF HEALTHCARE GLOBAL ENTERPRISES
| Pledged Promoter Shares |
5.52 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF HEALTHCARE GLOBAL ENTERPRISES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.79% 1.96% -18.02% -22.74% |
16.66% 18.57% -40.84% -61.14% |
| QtrlyTrend |
0 | |
| Latest Qtr: Jun2025 | ||
| Quarterly Result Analysis → | ||
HEALTHCARE GLOBAL ENTERPRISES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 0.9% | 3.5% | 0.8% |
| BSE HEALTHCARE | -0.8% | 4.2% | 4.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MICROCAP 250 | 0.6% | 3% | -0.6% |
| NIFTY TOTAL MARKET | 0.4% | 4.9% | 4.4% |
You may also like the below Video Courses
FAQ about HEALTHCARE GLOBAL ENTERPRISES
Is HEALTHCARE GLOBAL ENTERPRISES good for long term investment?
As on Oct 30,2025, the Fundamentals of HEALTHCARE GLOBAL ENTERPRISES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of HEALTHCARE GLOBAL ENTERPRISES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is HEALTHCARE GLOBAL ENTERPRISES UnderValued or OverValued?
As on Oct 30,2025, HEALTHCARE GLOBAL ENTERPRISES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES ?
As on Oct 30,2025, the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES is Rs. 464.21 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 484.05
Fair Value [Median EV / Sales Model] : Rs. 464.21
Fair Value [Median Price / Sales Model] : Rs. 436.53
Estimated Median Fair Value of HEALTHCARE GLOBAL ENTERPRISES : Rs. 464.21
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.